Gilead Sciences, Inc. (GILD)

Gilead Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	28,299	27,116	27,281	27,305	24,689	22,449
Revenue Growth (YoY)	3.31%	-0.60%	-0.09%	10.60%	9.98%	1.46%
Cost of Revenue	6,281	6,019	5,657	5,526	3,691	4,675
Gross Profit	22,018	21,097	21,624	21,779	20,998	17,774
Selling, General & Admin	5,194	5,537	5,673	5,246	5,112	4,381
Research & Development	5,637	5,758	4,998	4,601	4,927	4,055
Operating Expenses	10,831	11,295	10,671	9,847	10,039	8,436
Operating Income	11,187	9,802	10,953	11,932	10,959	9,338
Interest Expense	-980	-944	-935	-1,001	-984	-995
Interest & Investment Income	298	376	376	-	-	-
Currency Exchange Gain (Loss)	-11	-21	-21	-23	-	22
Other Non Operating Income (Expenses)	7	11	-279	-6	244	605
EBT Excluding Unusual Items	10,501	9,224	10,094	10,902	10,219	8,970
Merger & Restructuring Charges	-640	-527	-	-	-920	-
Gain (Loss) on Sale of Investments	41	-167	-657	-610	-1,662	1,241
Legal Settlements	-525	-525	-	-1,075	-	-
Other Unusual Items	51	60	21	-	-	-
Pretax Income	177	6,860	5,814	8,278	1,669	5,160
Income Tax Expense	63	1,247	1,248	2,077	1,580	-204
Earnings From Continuing Operations	114	5,613	4,566	6,201	89	5,364
Minority Interest in Earnings	12	52	26	24	34	22
Net Income	126	5,665	4,592	6,225	123	5,386
Net Income to Common	126	5,665	4,592	6,225	123	5,386
Net Income Growth	-97.86%	23.37%	-26.23%	4960.98%	-97.72%	-1.26%
Shares Outstanding (Basic)	1,247	1,248	1,255	1,256	1,257	1,270
Shares Outstanding (Diluted)	1,249	1,258	1,262	1,262	1,263	1,277
Shares Change (YoY)	-0.91%	-0.32%	-	-0.08%	-1.10%	-2.37%
EPS (Basic)	0.10	4.54	3.66	4.96	0.10	4.24
EPS (Diluted)	0.10	4.50	3.64	4.93	0.10	4.22
EPS Growth	-97.92%	23.63%	-26.17%	4938.22%	-97.68%	1.20%
Free Cash Flow	9,431	7,421	8,344	10,805	7,518	8,319
Free Cash Flow Per Share	7.55	5.90	6.61	8.56	5.95	6.51
Dividend Per Share	3.060	3.000	2.920	2.840	2.720	2.520
Dividend Growth	2.68%	2.74%	2.82%	4.41%	7.94%	10.53%
Gross Margin	77.80%	77.80%	79.26%	79.76%	85.05%	79.17%
Operating Margin	39.53%	36.15%	40.15%	43.70%	44.39%	41.60%
Profit Margin	0.45%	20.89%	16.83%	22.80%	0.50%	23.99%
Free Cash Flow Margin	33.33%	27.37%	30.59%	39.57%	30.45%	37.06%
EBITDA	13,949	12,495	13,056	13,982	12,439	10,742
EBITDA Margin	49.29%	46.08%	47.86%	51.21%	50.38%	47.85%
D&A For EBITDA	2,762	2,693	2,103	2,050	1,480	1,404
EBIT	11,187	9,802	10,953	11,932	10,959	9,338
EBIT Margin	39.53%	36.15%	40.15%	43.70%	44.39%	41.60%
Effective Tax Rate	35.59%	18.18%	21.47%	25.09%	94.67%	-
Revenue as Reported	28,299	27,116	27,281	27,305	24,689	22,449
Advertising Expenses	-	826	778	735	795	784

Source: S&P Capital IQ. Standard template. Financial Sources.